Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses

Qi-yuan Lva Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information

Hai-zhou Zoub Department of Oncology, Wenzhou Hospital of Traditional Chinese Medicine, Wenzhou, Zhejiang, ChinaView further author information

Yu-yan Xua Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information

Zhen-yong Shaoa Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information

Ruo-qi Wua Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information

Ke-jie Lia Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information

Xia Denga Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information

Dian-na Guc Department of Medical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaView further author information

Hong-xiao Jiangd Omigen, Inc, Hangzhou, PR ChinaView further author information

Meng Sua Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaCorrespondence[email protected]
View further author information

Chang-lin Zoua Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, ChinaCorrespondence[email protected]